- Home
- ULS vs ZBH Comparison
ULS vs ZBH Comparison
Compare ULS & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULS
- ZBH
- Stock Information
- Founded
- ULS 1894
- ZBH 1927
- Country
- ULS United States
- ZBH United States
- Employees
- ULS N/A
- ZBH N/A
- Industry
- ULS
- ZBH Industrial Specialties
- Sector
- ULS
- ZBH Health Care
- Exchange
- ULS Nasdaq
- ZBH Nasdaq
- Market Cap
- ULS 17.2B
- ZBH 19.9B
- IPO Year
- ULS 2024
- ZBH N/A
- Fundamental
- Price
- ULS $88.78
- ZBH $96.58
- Analyst Decision
- ULS Hold
- ZBH Buy
- Analyst Count
- ULS 8
- ZBH 19
- Target Price
- ULS $78.75
- ZBH $108.56
- AVG Volume (30 Days)
- ULS 583.2K
- ZBH 2.5M
- Earning Date
- ULS 11-04-2025
- ZBH 11-05-2025
- Dividend Yield
- ULS 0.60%
- ZBH 1.03%
- EPS Growth
- ULS 10.58
- ZBH N/A
- EPS
- ULS 1.67
- ZBH 4.03
- Revenue
- ULS $3,003,000,000.00
- ZBH $8,010,900,000.00
- Revenue This Year
- ULS $6.79
- ZBH $8.20
- Revenue Next Year
- ULS $6.23
- ZBH $5.92
- P/E Ratio
- ULS $52.16
- ZBH $23.19
- Revenue Growth
- ULS 6.68
- ZBH 5.47
- 52 Week Low
- ULS $48.54
- ZBH $85.33
- 52 Week High
- ULS $91.95
- ZBH $114.44
- Technical
- Relative Strength Index (RSI)
- ULS 66.63
- ZBH 56.43
- Support Level
- ULS $84.23
- ZBH $88.49
- Resistance Level
- ULS $88.27
- ZBH $91.28
- Average True Range (ATR)
- ULS 2.29
- ZBH 2.22
- MACD
- ULS -0.26
- ZBH 0.73
- Stochastic Oscillator
- ULS 96.20
- ZBH 99.39
About ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.